Magnus Essand

Board Director

Membre du Conseil

Elicera Therapeutics AB

Insider activity · 24 months1 buy0 salesCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 1 buy · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 12 Mar 2025 for Elicera Therapeutics AB, €7,283.

Filing timeline

BuySale

Magnus Essand

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Magnus Essand: trading record in brief

Magnus Essand has a single filing on record, published on 12 March 2025: a transaction of €7,283 in Elicera Therapeutics AB. One trade is not enough to describe a pattern. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Magnus Essand

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Elicera Therapeutics AB (SE)

Declarations1 total

▲
Magnus Essand
StyrelseledamotExecutives11 Mar 2025Elicera Therapeutics AB
€7,28316FI-SE
43,211 shares@ €0.16850.042% mcap100.0% of flowInterimsaktieISIN SE0015382080FI:A003M442-1
Canonical exit: 9 Jun 2025 (T+90)

1 of 1 declaration

Magnus Essand

Insider track record

Magnus Essand: trading record in brief

Companies and markets linked to Magnus Essand

Related entities